1. Home
  2. SSRM vs ORKA Comparison

SSRM vs ORKA Comparison

Compare SSRM & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SSR Mining Inc.

SSRM

SSR Mining Inc.

N/A

Current Price

$35.34

Market Cap

6.5B

Sector

Industrials

ML Signal

N/A

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

N/A

Current Price

$93.19

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSRM
ORKA
Founded
1946
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.1B
IPO Year
1997
1997

Fundamental Metrics

Financial Performance
Metric
SSRM
ORKA
Price
$35.34
$93.19
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$32.74
$92.50
AVG Volume (30 Days)
2.3M
728.6K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
243.41
N/A
EPS
N/A
N/A
Revenue
$1,629,637,000.00
N/A
Revenue This Year
$56.48
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
63.68
N/A
52 Week Low
$18.19
$14.67
52 Week High
$39.44
$115.52

Technical Indicators

Market Signals
Indicator
SSRM
ORKA
Relative Strength Index (RSI) 50.59 43.97
Support Level $28.41 $83.25
Resistance Level $36.40 $97.02
Average True Range (ATR) 1.27 4.87
MACD -0.60 -0.63
Stochastic Oscillator 20.60 37.62

Price Performance

Historical Comparison
SSRM
ORKA

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Share on Social Networks: